
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
SARS‐CoV‐2 Omicron BA.1 variant breakthrough infections in nursing home residents after an homologous third dose of the Comirnaty® COVID‐19 vaccine: Looking for correlates of protection
Ignacio Torres, Estela Giménez, Eliseo Albert, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 9, pp. 4216-4223
Open Access | Times Cited: 17
Ignacio Torres, Estela Giménez, Eliseo Albert, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 9, pp. 4216-4223
Open Access | Times Cited: 17
Showing 17 citing articles:
Neutralizing antibodies after three doses of the BNT162b2 vaccine, breakthrough infection, and symptoms during the Omicron-predominant wave
Shohei Yamamoto, Kouki Matsuda, Kenji Maeda, et al.
International Journal of Infectious Diseases (2023) Vol. 128, pp. 347-354
Open Access | Times Cited: 10
Shohei Yamamoto, Kouki Matsuda, Kenji Maeda, et al.
International Journal of Infectious Diseases (2023) Vol. 128, pp. 347-354
Open Access | Times Cited: 10
Omicron infection increases IgG binding to spike protein of predecessor variants
Gokulnath Mahalingam, Yogapriya Periyasami, Porkizhi Arjunan, et al.
Journal of Medical Virology (2022) Vol. 95, Iss. 2
Open Access | Times Cited: 12
Gokulnath Mahalingam, Yogapriya Periyasami, Porkizhi Arjunan, et al.
Journal of Medical Virology (2022) Vol. 95, Iss. 2
Open Access | Times Cited: 12
SARS-CoV-2 vaccine-induced antibodies protect against Omicron breakthrough infection
Eva Anna Marianne Baerends, Astrid Korning Hvidt, Joanne Reekie, et al.
iScience (2023) Vol. 26, Iss. 9, pp. 107621-107621
Open Access | Times Cited: 7
Eva Anna Marianne Baerends, Astrid Korning Hvidt, Joanne Reekie, et al.
iScience (2023) Vol. 26, Iss. 9, pp. 107621-107621
Open Access | Times Cited: 7
CD4+ and CD8+ T cells and antibodies are associated with protection against Delta vaccine breakthrough infection: a nested case-control study within the PITCH study
Isabel Neale, Mohammad Ali, Barbara Kronsteiner, et al.
mBio (2023) Vol. 14, Iss. 5
Open Access | Times Cited: 7
Isabel Neale, Mohammad Ali, Barbara Kronsteiner, et al.
mBio (2023) Vol. 14, Iss. 5
Open Access | Times Cited: 7
Peri-infection titers of neutralizing and binding antibodies as a predictor of COVID-19 breakthrough infections in vaccinated healthcare professionals: importance of the timing
Constant Gillot, Jean‐Louis Bayart, Mélanie Closset, et al.
Clinical Chemistry and Laboratory Medicine (CCLM) (2023) Vol. 61, Iss. 9, pp. 1670-1675
Open Access | Times Cited: 6
Constant Gillot, Jean‐Louis Bayart, Mélanie Closset, et al.
Clinical Chemistry and Laboratory Medicine (CCLM) (2023) Vol. 61, Iss. 9, pp. 1670-1675
Open Access | Times Cited: 6
CD4+ and CD8+ T cell and antibody correlates of protection against Delta vaccine breakthrough infection: A nested case-control study within the PITCH study
Isabel Neale, Mohammad Ali, Barbara Kronsteiner, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3
Isabel Neale, Mohammad Ali, Barbara Kronsteiner, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3
An epidemiological survey of COVID-19 serology and its association with clinical infection among older adults– does antibody titer matter?
Dvorah Sara Shapiro, Refael Ellis, Jowad Zidan, et al.
BMC Geriatrics (2024) Vol. 24, Iss. 1
Open Access
Dvorah Sara Shapiro, Refael Ellis, Jowad Zidan, et al.
BMC Geriatrics (2024) Vol. 24, Iss. 1
Open Access
Incidence of COVID-19 mRNA vaccine symptomatic breakthrough infections during Omicron circulation in adults with or without infection prior to vaccination
Christine Durier, Läétitia Ninove, Sylvie van der Werf, et al.
Infectious Diseases Now (2024) Vol. 54, Iss. 5, pp. 104886-104886
Open Access
Christine Durier, Läétitia Ninove, Sylvie van der Werf, et al.
Infectious Diseases Now (2024) Vol. 54, Iss. 5, pp. 104886-104886
Open Access
Cellular Immunity of SARS-CoV-2 in the Borriana COVID-19 Cohort: A Nested Case–Control Study
Salvador Domènech-Montoliu, Joan Puig‐Barberà, María Rosario Pac-Sa, et al.
Epidemiologia (2024) Vol. 5, Iss. 2, pp. 167-186
Open Access
Salvador Domènech-Montoliu, Joan Puig‐Barberà, María Rosario Pac-Sa, et al.
Epidemiologia (2024) Vol. 5, Iss. 2, pp. 167-186
Open Access
SARS‐CoV‐2‐Spike T‐cell response after receiving one or two Wuhan‐Hu‐1‐based mRNA COVID‐19 vaccine booster doses in elderly nursing home residents
Diego Carretero, Estela Giménez, Eliseo Albert, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 7
Open Access
Diego Carretero, Estela Giménez, Eliseo Albert, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 7
Open Access
Study of anti-S1-protein IgG antibody levels as potential correlates of protection against breakthrough infection with SARS-CoV-2 Omicron BA.1 and BA.2 variants
Ivana Kajanová, Žofia Rádiková, Ľubomíra Lukáčiková, et al.
Acta Virologica (2023) Vol. 67
Open Access | Times Cited: 1
Ivana Kajanová, Žofia Rádiková, Ľubomíra Lukáčiková, et al.
Acta Virologica (2023) Vol. 67
Open Access | Times Cited: 1
Correlation between specific antibody response to wild-type BNT162b2 booster and the risk of breakthrough infection with omicron variants: Impact of household exposure in hospital healthcare workers
Naoki Tani, Hideyuki Ikematsu, Takeyuki Goto, et al.
Vaccine (2023) Vol. 41, Iss. 45, pp. 6672-6678
Open Access | Times Cited: 1
Naoki Tani, Hideyuki Ikematsu, Takeyuki Goto, et al.
Vaccine (2023) Vol. 41, Iss. 45, pp. 6672-6678
Open Access | Times Cited: 1
Humoral and cellular immune responses in fully vaccinated individuals with or without SARS‐CoV‐2 breakthrough infection: Results from the CoV‐ADAPT cohort
Moritz M. Hollstein, Sascha Dierks, Michael P. Schön, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 10
Open Access | Times Cited: 1
Moritz M. Hollstein, Sascha Dierks, Michael P. Schön, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 10
Open Access | Times Cited: 1
Neutralizing antibodies following three doses of BNT162b2 vaccine, breakthrough infection, and symptoms during the Omicron predominant wave
Shohei Yamamoto, Kouki Matsuda, Kenji Maeda, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 2
Shohei Yamamoto, Kouki Matsuda, Kenji Maeda, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 2
Determinants of protection against SARS-CoV-2 Omicron BA.1 and Delta infections in fully vaccinated outpatients
Álvaro Roy, Carla Saade, Laurence Josset, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Álvaro Roy, Carla Saade, Laurence Josset, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
An epidemiological survey of COVID-19 serology and its association with clinical infection among older adults – Does antibody titer matter?
Dvorah Sara Shapiro, Refael Ellis, Jowad Zidan, et al.
Research Square (Research Square) (2023)
Open Access
Dvorah Sara Shapiro, Refael Ellis, Jowad Zidan, et al.
Research Square (Research Square) (2023)
Open Access